American Century Companies’s Akoya BioSciences AKYA Stock Holding History

American Century Companies’s Portfolio AKYA Stock Details AKYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-304,904	Closed	-$4.26M	–	2311
2021 Q3	$4.26M	Sell	304,904 -642	-0.2%	-$10.7K	﹤0.01%	1067
2021 Q2	$5.91M	Buy	+305,546	New	+$6.31M	﹤0.01%	949

Other funds holding AKYA

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

BWLSA

Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

American Century Companies's AKYA Position: Q4 2021 in Review

American Century Companies sold out of Akoya BioSciences (AKYA) in Q4 2021, closing a stake of 304,904 shares — an estimated $4.26M sold.

American Century Companies first reported a position in AKYA in Q2 2021 and held it in 2 quarters. The position peaked at $5.91M in Q2 2021. 45 funds tracked by Wall St. Rank hold AKYA as of Q4 2021.

American Century Companies reported no remaining Akoya BioSciences position as of Q4 2021 after selling out during the quarter.
American Century Companies sold 304,904 Akoya BioSciences shares in Q4 2021, an estimated $4.26M.
American Century Companies first reported a position in Akoya BioSciences in Q2 2021 and held it in 2 quarters.
American Century Companies's Akoya BioSciences position peaked at $5.91M in Q2 2021.
45 funds tracked by Wall St. Rank held Akoya BioSciences as of Q4 2021.

Based on American Century Companies's 13F filing for Q4 2021, filed 7 Feb 2022.